Looks like you clickedhttp://abbvie.mediaroom.com/2013-06-17-AbbVie-Presents-Preliminary-Results-from-Phase-I-Study-of-Investigational-Oncology-Compound-ABT-199-GDC-0199-in-Patients-with-High-Risk-Chronic-Lymphocytic-Leukemia-CLL-at-European-Hematology-Association-Annual-Meeting
If you do not want to visit that page, you can close this browser tab.
